Annelienke van Hulst

133 Determinants for side effects 4 REFERENCES 1. Veerman AJ, Kamps WA, van den Berg H, et al: Dexamethasone-based therapy for childhood acute lymphoblastic leukaemia: results of the prospective Dutch Childhood Oncology Group (DCOG) protocol ALL-9 (1997-2004). Lancet Oncol 10:957-66, 2009 2. Vrooman LM, Stevenson KE, Supko JG, et al: Postinduction dexamethasone and individualized dosing of Escherichia Coli L-asparaginase each improve outcome of children and adolescents with newly diagnosed acute lymphoblastic leukemia: results from a randomized study--DanaFarber Cancer Institute ALL Consortium Protocol 00-01. J Clin Oncol 31:1202-10, 2013 3. Bostrom BC, Sensel MR, Sather HN, et al: Dexamethasone versus prednisone and daily oral versus weekly intravenous mercaptopurine for patients with standard-risk acute lymphoblastic leukemia: a report from the Children’s Cancer Group. Blood 101:3809-17, 2003 4. McGrath P, Pitcher L: ‘Enough is enough’: qualitative findings on the impact of dexamethasone during reinduction/consolidation for paediatric acute lymphoblastic leukaemia. Support Care Cancer 10:146-55, 2002 5. McGrath P, Rawson-Huff N: Corticosteroids during continuation therapy for acute lymphoblastic leukemia: the psycho-social impact. Issues Compr Pediatr Nurs 33:5-19, 2010 6. Pound CM, Clark C, Ni A, et al: Corticosteroids, behavior, and quality of life in children treated for acute lymphoblastic leukemia; a multicentered trial. J Pediatr Hematol Oncol 34:517-23, 2012 7. Aljebab F, Choonara I, Conroy S: Systematic Review of the Toxicity of Long-Course Oral Corticosteroids in Children. PLoS One 12:e0170259, 2017 8. Hochhauser CJ, Lewis M, Kamen BA, et al: Steroid-induced alterations of mood and behavior in children during treatment for acute lymphoblastic leukemia. Support Care Cancer 13:967-74, 2005 9. Stuart FA, Segal TY, Keady S: Adverse psychological effects of corticosteroids in children and adolescents. Arch Dis Child 90:500-6, 2005 10. Warris LT, van den Heuvel-Eibrink MM, den Hoed MA, et al: Does dexamethasone induce more neuropsychological side effects than prednisone in pediatric acute lymphoblastic leukemia? A systematic review. Pediatr Blood Cancer 61:1313-8, 2014 11. Warris LT, van den Heuvel-Eibrink MM, Aarsen FK, et al: Hydrocortisone as an Intervention for Dexamethasone-Induced Adverse Effects in Pediatric Patients With Acute Lymphoblastic Leukemia: Results of a Double-Blind, Randomized Controlled Trial. J Clin Oncol 34:2287-93, 2016 12. Zupanec S, Jones H, Stremler R: Sleep Habits and Fatigue of Children Receiving Maintenance Chemotherapy for ALL and Their Parents. Journal of Pediatric Oncology Nursing 27:217-228, 2010 13. Rosen G, Harris AK, Liu M, et al: The effects of dexamethasone on sleep in young children with acute lymphoblastic leukemia. Sleep Med 16:503-9, 2015 14. Sheikh IN, Roth M, Stavinoha PL: Prevalence of Sleep Disturbances in Pediatric Cancer Patients and Their Diagnosis and Management. Children (Basel) 8, 2021 15. van Hulst AM, Peersmann SHM, van den Akker ELT, et al: Risk factors for steroid-induced adverse psychological reactions and sleep problems in pediatric acute lymphoblastic leukemia: A systematic review. Psychooncology 30:1009-1028, 2021 16. Manenschijn L, van den Akker EL, Lamberts SW, et al: Clinical features associated with glucocorticoid receptor polymorphisms. An overview. Ann N Y Acad Sci 1179:179-98, 2009

RkJQdWJsaXNoZXIy MTk4NDMw